Skip to main content

Table 6 Scenario analysis for men with low risk localised prostate cancer

From: The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer

Age at diagnosis (Years) ICER (Cost per QALY gained) Dominance
AS vs WW RP vs WW AS vs RP RP vs AS
Scenario one: using the 5% conversion rate
 45 - $6,441 - - AS was dominated by RP
 50 - $7,908 - - AS was dominated by RP
 55 - $10,361 - - AS was dominated by RP
 60 - $14,021 - - AS was dominated by RP
 65 - $21,226 - - AS was extended dominated by WW and RP
 70 $31,135 - - $33,140 -
Scenario two: using new quality of life inputs
 45 $11,060 - - - RP was extended dominated by WW and AS
 50 $12,602 - - - RP was extended dominated by WW and AS
 55 $14,814 - - - RP was dominated by AS
 60 $17,807 - - - RP was dominated by AS and by WW
 65 $21,916 - - - RP was dominated by AS and by WW
 70 $26,833 - - - RP was dominated by AS and by WW
Scenario three: using new costing inputs
 45 - $5,324 - - AS was dominated by RP
 50 - $6,613 - - AS was dominated by RP
 55 - $8,793 - - AS was dominated by RP
 60 - $12,332 - - AS was extended dominated by WW and RP
 65 $15,732 - - $24,000 -
 70 $19,364 - - $35,761 -
Scenario four: using new quality of life inputs and costing inputs
 45 $11,254 - - - RP was extended dominated by WW and AS
 50 $12,882 - - - RP was extended dominated by WW and AS
 55 $15,248 - - - RP was extended dominated by WW and AS
 60 $18,520 - - - RP was dominated by AS and by WW
 65 $23,184 - - - RP was dominated by AS and by WW
 70 $30,122 - - - RP was dominated by AS and by WW
Scenario five: using new quality of life values, costing values and the 5% conversion rate
 45 $22,904 - - - RP was extended dominated by WW and AS
 50 $27,385 - - - RP was extended dominated by WW and AS
 55 $33,790 - - - RP was extended dominated by WW and AS
 60 $44,090 - - - RP was dominated by WW
 65 $59,769 - - - RP was dominated by WW and by AS
 70 $101,360 - - - RP was dominated by WW and by AS
  1. RP radical prostatectomy, AS active surveillance, WW watchful waiting